We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 11-20 of 1,131

A Turkey In Every Patent
  • Foley & Lardner LLP
  • USA
  • November 22 2016

While not everyone in the U.S. will be eating turkey on Thursday, this website reports that 88 of Americans surveyed by the National Turkey


Swearing Behind A Reference With Reasonably Continuous Diligence
  • Foley & Lardner LLP
  • USA
  • November 16 2016

In Perfect Surgical Techniques, Inc. v. Olympus America, Inc., the Federal Circuit vacated and remanded a USPTO Patent Trial and Appeal Board


USPTO Examination Time Goals -- How Much Time Should Examiners Have To Examine A Patent Application?
  • Foley & Lardner LLP
  • USA
  • November 8 2016

As part of its ongoing efforts to improve patent quality, the USPTO is reevaluating its examination time goals and seeking public feedback on how


PTAB Post-Grant Fees Slated To Increase
  • Foley & Lardner LLP
  • USA
  • November 8 2016

The USPTO recently announced a proposed new fee schedule in a Notice of Proposed Rulemaking (NPRM) in search of revenue to recover its projected $3


USPTO Again Proposes To Revise Duty Of Disclosure In View Of Therasense
  • Foley & Lardner LLP
  • USA
  • October 31 2016

More than five years after the Federal Circuit’s en banc decision in Therasense and its first proposed rulemaking under that decision, the USPTO has


District Court Denies Extra Patent Term Adjustment When National Stage Entry Date Falls On A Holiday
  • Foley & Lardner LLP
  • USA
  • October 27 2016

Some patent term adjustment (PTA) cases have broad impact-like Wyeth v. Kappos and Novartis v. Lee-but Acetelion Pharmaceuticals, Inc. v. Lee


Biogen TYSABRI Patents Spared Inter Partes Review
  • Foley & Lardner LLP
  • USA
  • October 25 2016

The USPTO Patent Trial and Appeals Board (PTAB) declined to institute Inter Partes Review (IPR) proceedings against three Biogen Idec TYSABRI patents


The Decision To Grant Rehearing En Banc In Apple v. Samsung
  • Foley & Lardner LLP
  • USA
  • October 25 2016

On October 7, 2016, the Federal Circuit issued another decision in the ongoing patent litigations between Apple and Samsung that began in the Northern


USPTO Makes It Easy To Review Patent Assignment Documents
  • Foley & Lardner LLP
  • USA
  • October 20 2016

The USPTO has yet to implement new rules requiring applicants to promptly record patent ownership information, but it recently made it much easier to


Higher US Patent Fees On The Horizon
  • Foley & Lardner LLP
  • USA
  • October 18 2016

The USPTO has published a proposed fee schedule for patent fees likely to take effect October 1, 2017-the start of the USPTO’s next fiscal year. The